Equities

Astec Lifesciences Ltd

Astec Lifesciences Ltd

Actions
Basic MaterialsChemicals
  • Price (INR)1,233.80
  • Today's Change8.80 / 0.72%
  • Shares traded25.21k
  • 1 Year change-8.61%
  • Beta0.4857
Data delayed at least 15 minutes, as of Sep 20 2024 10:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments4.724.735.55
Total Receivables, Net1,9251,9523,147
Total Inventory1,9722,9611,911
Prepaid expenses505049
Other current assets, total332144
Total current assets3,9854,9895,157
Property, plant & equipment, net5,3164,2923,514
Goodwill, net------
Intangibles, net194159114
Long term investments0.050.050.05
Note receivable - long term15825987
Other long term assets979696
Total assets9,7499,7948,968
LIABILITIES
Accounts payable8931,7721,898
Accrued expenses------
Notes payable/short-term debt2,8302,8532,394
Current portion long-term debt/capital leases119450400
Other current liabilities, total130187214
Total current liabilities3,9725,2624,906
Total long term debt1,9901090
Total debt4,9393,4122,794
Deferred income tax6821081
Minority interest2.311.921.63
Other liabilities, total251814
Total liabilities6,0565,6015,003
SHAREHOLDERS EQUITY
Common stock196196196
Additional paid-in capital611607603
Retained earnings (accumulated deficit)2,8823,3863,162
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total0.060.220.12
Total equity3,6934,1943,965
Total liabilities & shareholders' equity9,7499,7948,968
Total common shares outstanding202020
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.